Delivery Order SPE2DB24D2205-SPE2DB25FDZRF
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,069.26 contract is for the delivery of 4568495958 - LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a diabetes medication. The order has a completion date of June 10, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,405.49, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,629.46, is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,266.50, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, to support federal healthcare programs. The contract is a firm fixed-price delivery order with a completion date of January 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.56, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order contract. The contract was not set aside for any specific...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The award has a ceiling value of $1,835.04 and a completion date of July 7, 2025. This is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,241.82, is for the delivery of LIRAGLUTIDE 2-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a Firm Fixed Price agreement. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes medication, with a ceiling value of $8,945.99 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, indicating the order is for a specific quantity of a product at a predetermined price....
This is a $4,341.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a diabetes treatment medication. The contract has an ultimate completion date of June 10, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,007.13, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...